Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.24.1.1.u2
Cover - shares
 3 Months Ended
Mar. 31, 2024
May 09, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41231  
Entity Registrant Name TC BIOPHARM (HOLDINGS) PLC  
Entity Central Index Key 0001872812  
Entity Tax Identification Number 00-0000000  
Entity Incorporation, State or Country Code X0  
Entity Address, Address Line One Maxim 1, 2 Parklands Way  
Entity Address, Address Line Two Holytown  
Entity Address, City or Town Motherwell  
Entity Address, Country GB  
Entity Address, Postal Zip Code ML1 4WR  
City Area Code +44 (0)  
Local Phone Number 141 433 7557  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   98,902,641
American Depositary Shares, each representing one Ordinary Share, nominal value £0.0001 per share    
Title of 12(b) Security American Depositary Shares, each representing twenty Ordinary Shares, nominal value £0.0001 per share  
Trading Symbol TCBP  
Security Exchange Name NASDAQ  
Warrants, each warrant representing the right to purchase one American Depositary Share    
Title of 12(b) Security Warrants, each warrant representing the right to purchase one American Depositary Share  
Trading Symbol TCBPW  
Security Exchange Name NASDAQ